All News #Library
Biotech
Recludix Pharma Secures Funds For Novel SH2 Domain Inhibitors
12 Jan 2026 //
GLOBENEWSWIRE
Recludix Doses First Subjects in Phase 1 STAT6 Inhibitor Study
12 Jan 2026 //
GLOBENEWSWIRE
Recludix Pharma Strengthens Scientific Advisory Board
08 Jan 2026 //
GLOBENEWSWIRE
Recludix Names STAT6 Inhibitor Candidate Under Sanofi Deal
02 Jun 2025 //
GLOBENEWSWIRE
Recludix Presents Data on First-in-Class BTK SH2 Domain Inhibitor
07 May 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support